Related Experiment Video
Updated: Jun 11, 2026

Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
Changes in neurohormonal gut peptides following bariatric surgery
C N Ochner1, C Gibson, M Shanik
1New York Obesity Research Center, Department of Medicine, St Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY 10025, USA. co2193@columbia.edu
Abstract:
The rising prevalence of obesity has reached pandemic proportions, with an associated cost estimated at up to 7% of health expenditures worldwide. Bariatric surgery is currently the only effective long-term treatment for obesity and obesity-related co-morbidities in clinically severely obese patients. However, the precise physiological mechanisms underlying the postsurgical reductions in caloric intake and body weight are poorly comprehended. It has been suggested that changes in hormones involved in hunger, food intake and satiety via the neurohormonal network may contribute to the efficacy of bariatric procedures. In this review, we consider how gastrointestinal hormone concentrations, involved in appetite and body weight regulation via the gut-brain axis, are altered by different bariatric procedures. Special emphasis is placed on neurohormonal changes following Roux-en-Y gastric bypass surgery, which is the most common and effective procedure used today.
Related Concept Videos
Hormonal Regulation
Regulation of Food Intake
Gut-Brain Axis
Neural Regulation
Intestinal Phase of Digestion
The arrival of the chyme in the small intestine distends the duodenum, which triggers the enterogastric reflex. This distension...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

